Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

2 FTSE 100 stocks I’d sell in June

| G A Chester

G A Chester explains why he believes the valuations of these two FTSE 100 (INDEXFTSE:UKX) stocks are far too high.

Read more »

Investing Articles

Why I think AstraZeneca is a must-buy dividend stock

| Kirsteen Mackay

A steadily climbing share price, varied product development and positive trial results point to continued success for this big pharma…

Read more »

Investing Articles

2 FTSE 100 world-beating income growth stocks I’d buy to hold forever

| Rupert Hargreaves

These FTSE 100 (INDEXFTSE:UKX) stocks have a track record of creating wealth for investors, that's why they're fantastic buy-and-hold investments…

Read more »

Investing Articles

Will the AstraZeneca share price be boosted by positive trial results?

| Stepan Lavrouk

AstraZeneca plc (LON: AZN) reports excellent data for cancer drug Lynparza. Can this help drive the share price upwards?

Read more »

Investing Articles

Top shares for June 2019

| The Motley Fool Staff

We asked our freelance writers to share their top stock picks for the month.

Read more »

Investing Articles

Is the AstraZeneca share price a FTSE 100 bargain?

| G A Chester

G A Chester discusses the investment case for FTSE 100 (INDEXFTSE:UKX) giant AstraZeneca plc (LON:AZN) and a small-cap pharma firm…

Read more »

Investing Articles

Will AstraZeneca’s new strategy make the share price soar?

| Stepan Lavrouk

A pivot to cancer treatment has been profitable for AstraZeneca plc (LON:AZN), but can it last?

Read more »

Investing Articles

Can the AstraZeneca share price reach 6,000p in 2019?

| Alan Oscroft

The AstraZeneca plc (LON: AZN) share price has been soaring, but here's why I think the bulls might be getting…

Read more »

Investing Articles

Top shares for May 2019

| The Motley Fool Staff

We asked our freelance writers to share their top stock picks for the month.

Read more »

Investing Articles

Expensive but exceptional! 2 FTSE 100 stocks I’d buy following latest news

| Royston Wild

These FTSE 100 (INDEXFTSE: UKX) shares might not be the cheapest. But if you're looking to make big returns, Royston…

Read more »

Investing Articles

Forget the Cash ISA. Here are 2 FTSE 100 stocks I’d buy and hold forever

| Rupert Hargreaves

These FTSE 100 (INDEXFTSE: UKX) income champions yield nearly three times as much as the best Cash ISA on the…

Read more »

Investing Articles

Should I buy GSK shares or FTSE 100 rival AstraZeneca?

| G A Chester

G A Chester weighs the merits of FTSE 100 (INDEXFTSE:UKX) pharmaceuticals giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:GSK).

Read more »